Adam works with MediPharm Labs as Head of Strategic Accounts (Asia Pacific). Prior to joining MediPharm Labs, Adam spent over 8 years building various B2B businesses within education, investment, and medicinal cannabis, with progressive roles including business development, strategy, product development and project management. He has consulted private and listed cannabis producers and ancillary businesses since 2015, as one of the early entrants and experts in the burgeoning Australian cannabis industry. Adam founded and currently sits on the board of The Medical Cannabis Council, Australia’s largest not-for-profit industry body. He is a frequent public speaker and publishes a widely read industry newsletter. Adam earned a Bachelor of Entrepreneurship from the Royal Melbourne Institute of Technology.

Adam has appeared in several major news outlets including the Sydney Morning Herald, The Australian Financial Review, Startup Smart, SBS, SkyNews, MJBizDaily, and other major publications.

Paul is a registered Australian and UK pharmacist.  His company Health House was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Over the last 30 years he has owned several retail pharmacies and worked both in Australia and the UK. In the last 3 years he has focussed on researching medicinal cannabis and has been to conferences, grow and manufacturing facilities and spoken to patients and prescribers in the US, Canada, Israel and recently South America. www.healthhouse.com.au

Sharlene is a Medical Scientist (BAppSc -Medical Laboratory Science) and director of Medical Cannabis Research Australia who has been researching how Medical Cannabis may treat an ever-increasing array of disorders. Her university background in diagnostic pathology gives her the knowledge to understand disease processes in the human body. 

She’s travelled to the US, Canada, Israel, Colombia and Chile to learn firsthand from the leading researchers in this new field of cannabinoid science. She’s passionate about sharing this knowledge by educating others under the banner of her charity Medical Cannabis Research Australia. She is committed to advocating for use and access to medical cannabis for patients in Australia as well as promoting more research to give clinicians the evidence they require to pursue this treatment for their patients, both in Australia and in the rest of the world.

School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong;

The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE)

Dr Katrina Green is a medical sciences lecturer in the School of Medicine, University of Wollongong. She is also a scientific affiliate of ACRE, the Australian Federal Government funded cannabinoid research centre that conducts collaborative research across the broad fields of plant sciences, pre-clinical and clinical research, and health policy and practice.

Dr Green has 13 years of cannabinoid medical research experience and leads a vibrant lab team who are developing new therapeutic approaches to treating illnesses of the brain. She has a keen interest in the benefits of cannabidiol (CBD) and other compounds found in hemp plants, eg terpenes and flavonoids, as well as their interactions (the ‘entourage effect’). She will present on her recent publication “The United Chemicals of Cannabis” (http://bit.ly/2UVWZ8w), which examines scientific evidence showing that certain cannabis compounds can improve brain health. Her talk will highlight the potential of hemp plants to enable the discovery of new medicines in this area.

FRACGP FRNZCUCP FRNZCGP BHB MBChB PGDipSpMed PGDipCEM

Director of Cannabis Doctors Australia and CDA Health Educator, Advocate and Presciber of Medicinal Cannabis